Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Cancer. 2012 Jan 17;118(17):4244–4252. doi: 10.1002/cncr.27382

Table 4.

Xerostomia Related Quality of Life Scale (XeQOLS) Change Scores

ALTENS
(N=47)
Not Evaluated at 6 months 12 (26%)
Evaluated at 6 months 35 (74%)
 Treatment Response*
  Yes 30 (86%)
  No 5 (14%)
 Percent Change in XeQOLS Score
  Mean (Std. Dev.) −35.9 (36.1)
  Minimum −100
  1st Quartile −58
  Median −42.9
  3rd Quartile −21.7
  Maximum 111

Percent change scores 6 months after initiation of treatment from baseline score.

*

At least 20% reduction (percent change ≤-20)

Negative values indicate lower XeQOLS score and reduced xerostomia burden.